NDC 80425-0198-01 - Cefadroxil
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0198
- Requested NDC
- 80425-0198-01
- Package NDCs from labels
- 80425-0198-2, 80425-0198-1, 80425-0198-3, 80425-0198-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-02-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Cefadroxil - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-02-09 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0198-1 | Cefadroxil | 10 in 1 BOTTLE | CAPSULE | 10 | 6 | |
| 80425-0198-2 | Cefadroxil | 30 in 1 BOTTLE | CAPSULE | 30 | 6 | |
| 80425-0198-3 | Cefadroxil | 20 in 1 BOTTLE | CAPSULE | 20 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0198 | CEFADROXIL CAPSULE [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 6 | Current NDC, Legacy NDC, 3 package rows | 20240210_ec836a53-7ed1-79b9-e053-2a95a90a9c36.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0198-1 | EA - Each | 80425-0198 | fa6bd022-72c2-49de-bfe1-dfbaf2458edb | 1 | 2023-06-06 |
| 80425-0198-2 | EA - Each | 80425-0198 | 60265ca7-1c82-4fa4-9812-67a2a18e68ac | 1 | 2023-06-06 |
| 80425-0198-3 | EA - Each | 80425-0198 | 88c9d8eb-6a94-4384-b6a3-712df2260789 | 1 | 2024-03-12 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cefadroxil | CEFADROXIL | NuCare Pharmaceuticals,Inc. | a218d8d3-af90-4599-e053-2995a90a0ede | 2024-06-20 | Warnings, Adverse reactions | ANDA065352 309049 280111G160 |
| Cefadroxil | CEFADROXIL | NuCare Pharmaceuticals,Inc. | 8bdd68a4-4e2e-0170-e053-2a95a90adb78 | 2024-06-18 | Warnings, Adverse reactions | ANDA065352 309049 280111G160 |
| Cefadroxil | CEFADROXIL | NuCare Pharmaceuticals,Inc. | 7278a39f-9de1-c9e2-e053-2a91aa0aea34 | 2024-06-10 | Warnings, Adverse reactions | ANDA065352 309049 280111G160 |
| Cefadroxil | CEFADROXIL | Advanced Rx Pharmacy of Tennessee, LLC | 1a50b564-b00f-58e4-e063-6294a90af2c6 | 2024-06-07 | Warnings, Adverse reactions | ANDA065352 309049 280111G160 |
| Cefadroxil | CEFADROXIL | NuCare Pharmaceuticals,Inc. | 16f3dd01-650a-2426-e063-6394a90a1b4b | 2024-04-25 | Warnings, Adverse reactions | ANDA065352 309049 280111G160 |
| Cefadroxil | CEFADROXIL | Bryant Ranch Prepack | 672519a7-11a1-4d8e-b2ca-dc9598c2f179 | 2024-04-03 | Warnings, Adverse reactions | ANDA065352 309049 280111G160 |
| Cefadroxil | CEFADROXIL | Bryant Ranch Prepack | 9c3bed82-6df0-4643-944a-a826f7dc018f | 2024-04-03 | Warnings, Adverse reactions | ANDA065352 309049 280111G160 |
| Cefadroxil | CEFADROXIL | Bryant Ranch Prepack | 8cdaac56-b84a-4b6b-b94d-cab15d5961c5 | 2024-04-03 | Warnings, Adverse reactions | ANDA065352 309049 280111G160 |
| Cefadroxil | CEFADROXIL | A-S Medication Solutions | 41ab333a-fafb-4647-844e-f3b2a76723cb | 2024-02-15 | Warnings, Adverse reactions | ANDA065352 309049 280111G160 |
| Cefadroxil | CEFADROXIL | Advanced Rx Pharmacy of Tennessee, LLC | ec836a53-7ed1-79b9-e053-2a95a90a9c36 | 2024-02-09 | Warnings, Adverse reactions | ANDA065352 80425-0198-2 80425-0198-3 80425-0198-1 80425-0198 80425019801 309049 10f671c2-e1e0-da2f-e063-6394a90a8724 ec836a53-7ed1-79b9-e053-2a95a90a9c36 280111G160 |
| Cefadroxil | CEFADROXIL | NorthStar Rx LLC | 30bb3686-87b4-4676-9ff5-e20deb8bff9d | 2024-02-09 | Warnings, Adverse reactions | 280111G160 |
| Cefadroxil | CEFADROXIL | Rising Pharma Holdings, Inc. | 6e4111d3-f11b-403c-b340-b216022709df | 2024-02-09 | Warnings, Adverse reactions | 280111G160 |
| Cefadroxil | CEFADROXIL | Aurobindo Pharma Limited | 776a8dbc-e68e-4732-acf4-0133dca0f54c | 2024-02-09 | Warnings, Adverse reactions | 280111G160 |
| Cefadroxil | CEFADROXIL | Rising Pharma Holdings, Inc. | 74c99fd8-16d1-4d2c-9158-42ff5eed2b7c | 2024-01-30 | Warnings, Adverse reactions | ANDA065352 57237-096 309049 15dc4c1d-6a9a-4c87-a037-e6fc34d84ad9 74c99fd8-16d1-4d2c-9158-42ff5eed2b7c 280111G160 |
| Cefadroxil | CEFADROXIL | Aurobindo Pharma Limited | 7bb90096-14d3-400e-94d3-048bff6b1292 | 2024-01-30 | Warnings, Adverse reactions | ANDA065352 309049 280111G160 |
| Cefadroxil | CEFADROXIL | NorthStar Rx LLC | 17123057-58c7-401a-b87d-8c4c0764bbf6 | 2024-01-30 | Warnings, Adverse reactions | ANDA065352 309049 280111G160 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.